In CCA, BRAF mutations are uncommon, occurring almost exclusively in iCCAs, with a prevalence ranging between 5% and 7%, and with the BRAFV600E mutation in 1.5% of patients with iCCA [26,73]. The gene discussed is BRAF; the disease is cholangiocarcinoma.